Highnoon Laboratories Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Adeel Haider
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 9.9yrs |
CEO ownership | n/a |
Management average tenure | 1.4yrs |
Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Adeel Haider
9.9yrs
Tenure
Dr. Adeel Abbas Haider serves as Chief Executive Officer, Managing Director at Highnoon Laboratories Ltd and serves as its Vice Chairman since 2025 and served as its Executive Director of Strategic Plannin...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Vice Chairman | no data | no data | no data | |
Chief Financial Officer | less than a year | no data | no data | |
Sr. General Counsel & Company Secretary | less than a year | no data | no data | |
Director of HR & Strategic Planning | no data | no data | no data | |
Chief Business Officer | no data | no data | no data | |
Chief Commercial Officer | no data | no data | 0.0024% PKR 1.1m | |
Chief Operating Officer - Route2Health | 2.2yrs | no data | no data | |
MD of Curexa & Director | no data | no data | no data | |
Head Internal Auditor | 2.2yrs | no data | no data |
1.4yrs
Average Tenure
Experienced Management: HINOON's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Vice Chairman | 9.9yrs | no data | no data | |
MD of Curexa & Director | no data | no data | no data | |
Chairman | 18.5yrs | no data | 7.48% PKR 3.5b | |
Director | less than a year | no data | 11.83% PKR 5.5b | |
Non Executive Director | no data | no data | 9.87% PKR 4.6b | |
Director | less than a year | no data | 0.00024% PKR 112.6k | |
Female Director | 1.2yrs | no data | no data | |
Independent Director | less than a year | no data | no data |
0.8yrs
Average Tenure
Experienced Board: HINOON's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/03/22 19:43 |
End of Day Share Price | 2025/03/21 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Highnoon Laboratories Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Arvind Anand | Fortune Securities Limited |
Farhana Shahid | M. M. Securities Private Limited |